Risk for ischemic heart disease and all-cause mortality in subclinical hypothyroidism

Journal of Clinical Endocrinology and Metabolism

Volumn 89, Issue 7, 2004, Pages 3365-3370

  Imaizumi, Misa ^a,b   Akahoshi, Masazumi ^a   Ichimaru, Shinichiro ^a   Nakashima, Eiji ^a   Hida, Ayumi ^a   Soda, Midori ^a   Usa, Toshiro ^b   Ashizawa, Kiyoto ^b   Yokoyama, Naokata ^c   Maeda, Renju ^a   Nagataki, Shigenobu ^d   Eguchi, Katsumi ^b  

^a RADIATION EFFECTS RESEARCH FOUNDATION   (Japan)

^b NAGASAKI UNIVERSITY   (Japan)

^c Nagasakiken Saiseikai Hospital   (Japan)

^d Japan Radioisotope Association   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CAUSE OF DEATH; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; HYPOTHYROIDISM; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SURVIVAL RATE;

AGED; AUTOANTIBODIES; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPOTHYROIDISM; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PREVALENCE; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; SEX DISTRIBUTION; THYROID GLAND;

EID: 3242693967     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2003-031089     Document Type: Article

References (33)

1. Canaris GJ, Manowitz NR, Mayor G, Ridgway EC 2000 The Colorado thyroid disease prevalence study. Arch Intern Med 160:526-534
2. Sawin CT, Castelli WP, Hershman JM, McNamara P, Bacharach P 1985 The aging thyroid. Thyroid deficiency in the Framingham Study. Arch Intern Med 145:1386-1388
3. Tunbridge WM, Evered DC, Hall R, Appleton D, Brewis M, Clark F, Evans JG, Young E, Bird T, Smith PA 1977 The spectrum of thyroid disease in a community: the Whickham survey. Clin Endocrinol (Oxf) 7:481-493
4. Pucci E, Chiovato L, Pinchera A 2000 Thyroid and lipid metabolism. Int J Obes Relat Metab Disord 24(Suppl 2):S109-S112
5. Caron P, Calazel C, Parra HJ, Hoff M, Louvet JP 1990 Decreased HDL cholesterol in subclinical hypothyroidism: the effect of L-thyroxine therapy. Clin Endocrinol (Oxf) 33:519-523
6. Althaus BU, Staub JJ, Ryff-De Leche A, Oberhansli A, Stahelin HB 1988 LDL/HDL-changes in subclinical hypothyroidism: possible risk factors for coronary heart disease. Clin Endocrinol (Oxf) 28:157-163
7. Biondi B, Fazio S, Palmieri EA, Carella C, Panza N, Cittadini A, Bone F, Lombardi G, Sacca L 1999 Left ventricular diastolic dysfunction in patients with subclinical hypothyroidism. J Clin Endocrinol Metab 84:2064-2067
8. Kahaly GJ 2000 Cardiovascular and atherogenic aspects of subclinical hypothyroidism. Thyroid 10:665-679
9. Monzani F, Del Guerra P, Caraccio N, Pruneti CA, Pucci E, Luisi M, Baschieri L 1993 Subclinical hypothyroidism: neurobehavioral features and beneficial effect of L-thyroxine treatment. Clin Investig 71:367-371
10. Tieche M, Lupi GA, Gutzweller F, Grob PJ, Studer H, Burgi H 1981 Borderline low thyroid function and thyroid autoimmunity. Risk factors for coronary heart disease? Br Heart J 46:202-206
11. Hak AE, Pols HA, Visser TJ, Drexhage HA, Hofman A, Witteman JC 2000 Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam Study. Ann Intern Med 132:270-278
12. Dean JW, Fowler PB 1985 Exaggerated responsiveness to thyrotrophin releasing hormone: a risk factor in women with coronary artery disease. Br Med J (Clin Res Ed) 290:1555-1561
13. Heinonen OP, Gordin A, Aho K, Punsar S, Pyorala K, Puro K 1972 Symptomless autoimmune thyroiditis in coronary heart-disease. Lancet 1:785-786
14. Bastenie PA, Banhaelst L, Bonnyns M, Neve P, Staquet M 1971 Preclinical hypothyroidism: a risk factor for coronary heart-disease. Lancet 1:203-204
15. Bastenie PA, Vanhaelst L, Neve P 1967 Coronary artery disease in hypothyroidism. Lancet 2:1221-1222
16. Vanderpump MP, Tunbridge WM, French JM, Appleton D, Bates D, Clark F, Grimley Evans J, Rodgers H, Tunbridge F, Young ET 1996 The development of ischemic heart disease in relation to autoimmune thyroid disease in a 20-year follow-up study of an English community. Thyroid 6:155-160
17. Nagataki S, Shibata Y, Inoue S, Yokoyama N, Izumi M, Shimaoka K 1994 Thyroid diseases among atomic bomb survivors in Nagasaki. JAMA 272:364-370
18. Commission ABC 1962 Research plan for joint ABCC-NIH Adult Health Study in Hiroshima and Nagasaki. Hiroshima and Nagasaki, Japan. ABCC Technical Report 11-62, Hiroshima, Japan: Atomic Bomb Casualty Commission
19. Roesch WC, ed 1987 U.S.-Japan Joint Reassessment of Atomic Bomb Radiation Dosimetry in Hiroshima and Nagasaki. Hiroshima, Japan: Radiation Effects Research Foundation
20. K Shizume HD, Takano K 1978 Studies of TSH radioimmunoassay kit, Eiken. Horumon To Rinsho 26:1063-1066
21. Alberti KG, Zimmet PZ 1998 Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15: 539-553
22. Vanhaelst L, Neve P, Chailly P, Bastenie PA 1967 Coronary-artery disease in hypothyroidism. Observations in clinical myxoedema. Lancet 2:800-802
23. Steinberg AD 1968 Myxedema and coronary artery disease - a comparative autopsy study. Ann Intern Med 68:338-344
24. Klein I, Ojamaa K 2001 Thyroid hormone and the cardiovascular system. N Engl J Med 344:501-509
25. Bigos ST, Ridgway EC, Kourides IA, Maloof F 1978 Spectrum of pituitary alterations with mild and severe thyroid impairment. J Clin Endocrinol Metab 46:317-325
26. Parle JV, Franklyn JA, Cross KW, Jones SR, Sheppard MC 1992 Circulating lipids and minor abnormalities of thyroid function. Clin Endocrinol (Oxf) 37:411-414
27. Bogner U, Arntz HR, Peters H, Schleusener H 1993 Subclinical hypothyroidism and hyperlipoproteinaemia: indiscriminate L-thyroxine treatment not justified. Acta Endocrinol (Copenh) 128:202-206
28. Kung AW, Pang RW, Janus ED 1995 Elevated serum lipoprotein(a) in subclinical hypothyroidism. Clin Endocrinol (Oxf) 43:445-449
29. Yildirimkaya M, Ozata M, Yilmaz K, Kilinc C, Gundogan MA, Kutluay T 1996 Lipoprotein(a) concentration in Subclinical hypothyroidism before and after levo-thyroxine therapy. Endocr J 43:731-736
30. Caraccio N, Ferrannini E, Monzani F 2002 Lipoprotein profile in Subclinical hypothyroidism: response to levothyroxine replacement, a randomized placebo-controlled study. J Clin Endocrinol Metab 87:1533-1538
31. Tzotzas T, Krassas GE, Konstantinidis T, Bougoulia M 2000 Changes in lipoprotein(a) levels in overt and subclinical hypothyroidism before and during treatment. Thyroid 10:803-808
32. Sellitti DF, Hill R, Doi SQ, Akamizu T, Czaja J, Tao S, Koshiyama H 1997 Differential expression of thyrotropin receptor mRNA in the porcine heart. Thyroid 7:641-646
33. Drvota V, Janson A, Norman C, Sylven C, Haggblad J, Bronnegard M, Marcus C 1995 Evidence for the presence of functional thyrotropin receptor in cardiac muscle. Biochem Biophys Res Commun 211:426-431